Da Silva Jorge Santos
Chief Executive Officer at MoonLake Immunotherapeutics
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: MoonLake Immunotherapeutics, 2 years.
MoonLake Immunotherapeutics
Director · Chief Executive Officer
Chief executive roles
MoonLake Immunotherapeutics
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2025 | MoonLake Immunotherapeutics | Grant or award | +95,763 | — | — |
| Feb 29, 2024 | MoonLake Immunotherapeutics | Open-market sale | −4,740 | $55.89 | $264,919 |
| Feb 28, 2024 | MoonLake Immunotherapeutics | Open-market sale | −56,065 | $55.00 | $3,083,575 |
| Feb 27, 2024 | MoonLake Immunotherapeutics | Open-market sale | −62,810 | $55.00 | $3,454,550 |
| Feb 21, 2024 | MoonLake Immunotherapeutics | Open-market sale | −1,125 | $55.27 | $62,179 |
| Feb 20, 2024 | MoonLake Immunotherapeutics | Open-market sale | −20,000 | $57.44 | $1,148,800 |
| Feb 16, 2024 | MoonLake Immunotherapeutics | Open-market sale | −20,000 | $60.15 | $1,203,000 |
| Feb 15, 2024 | MoonLake Immunotherapeutics | Open-market sale | −20,000 | $60.18 | $1,203,600 |
| Oct 1, 2023 | MoonLake Immunotherapeutics | Derivative conversion | +3,027,483 | — | — |
| Oct 1, 2023 | MoonLake Immunotherapeutics | Sold back to the company | −3,027,483 | — | — |
| Oct 1, 2023 | MoonLake Immunotherapeutics | Derivative conversion | +140,071 | — | — |
| Oct 1, 2023 | MoonLake Immunotherapeutics | Sold back to the company | −140,071 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.